Compare uniQure N.V. Ordinary Shares (QURE) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Seagate Technology Holdings PLC — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while Seagate Technology Holdings PLC trades at $676.5 (market cap $162.25B). The key difference: Seagate Technology Holdings PLC is far larger — about 111.9× uniQure N.V. Ordinary Shares's market cap, and Seagate Technology Holdings PLC pays a 0.41% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Seagate Technology Holdings PLC for 41 Days on average.
| QURE | STX | |
|---|---|---|
Market Cap | $1.45B | $162.25B |
Volume | 3,323,243 | 4,208,805 |
Sector | Health | Technology |
52-Week High | $70.59 | $1.09K |
52-Week Low | $9.03 | $214.40 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $707.46M | $164.41B |
Dividend Yield | — | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Seagate Technology (STX) trades at $746.86, down 0.85% amid recent sector pressure from Toshiba's AI storage expansion plans. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $5.71 vs. $5.10, continuing a trend of earnings outperformance. Technical indicators signal bearish momentum with the price near support at $746, while RSI levels suggest potential oversold conditions. Revenue recovery continues with 2025 reaching $9.10B and 2026 projected at $12.20B, driving improved profitability margins.
Despite near-term competitive headwinds, Seagate maintains strong analyst support with 55.77% buy ratings and $1,130 consensus price target representing 51% upside. The company's dominant position in AI data storage and robust 371.53% ROE support long-term growth prospects, though investors face risks from increased competition and volatile memory pricing cycles that could pressure margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
